Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. (Q37502702)

20 August 2017

1 reference

title

Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. (English)

1 reference

20 August 2017

1 reference

1

Peter Carmeliet

1 reference

20 August 2017

Frederik De Smet

2

1 reference

20 August 2017

Sonja Loges

series ordinal

3

1 reference

20 August 2017

Massimiliano Mazzone

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

Nature Reviews Clinical Oncology

20 August 2017

1 reference

20 August 2017

6

1 reference

20 August 2017

315-326

1 reference

20 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2009.64

20 August 2017

0 references

cites work

Tracheal branching morphogenesis in Drosophila: new insights into cell behaviour and organ architecture

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

VEGF inhibition: insights from preclinical and clinical studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

VEGF-targeted therapy: mechanisms of anti-tumour activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Autocrine VEGF signaling is required for vascular homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Cellular abnormalities of blood vessels as targets in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

The role of endothelial-to-mesenchymal transition in cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

A role for VEGF as a negative regulator of pericyte function and vessel maturation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Notch signaling regulates tumor angiogenesis by diverse mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

The many facets of Notch ligands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Notch signaling in blood vessels: who is talking to whom about what?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Wnt/Notch signalling and information processing during development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Blockade of Notch signaling in tumor-bearing mice may lead to tumor regression, progression, or metastasis, depending on tumor cell types

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Notch and cancer: a double-edged sword

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Molecular biology and pathology of lymphangiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

A genetic Xenopus laevis tadpole model to study lymphangiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Blocking neuropilin-2 function inhibits tumor cell metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

The semaphorins: versatile regulators of tumour progression and tumour angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Neuropilins in neoplasms: expression, regulation, and function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Selective requirements for NRP1 ligands during neurovascular patterning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Selective regulation of arterial branching morphogenesis by synectin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Guidance of vascular and neural network formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Neuropilins in physiological and pathological angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

In vivo analysis reveals a critical role for neuropilin-1 in cranial neural crest cell migration in chick.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Modulation of VEGF signalling output by the Notch pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Negative feedback regulation of Met-dependent invasive growth by Notch

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Neuropilin-1 participates in wound angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Deficiency of neuropilin 2 suppresses VEGF-induced retinal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

gamma-Secretase: a multifaceted regulator of angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Perivascular nitric oxide gradients normalize tumor vasculature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Antiangiogenic therapy: a universal chemosensitization strategy for cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.64

Abnormal lymphatic vessel development in neuropilin 2 mutant mice.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19483738

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19483738

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19483738

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2009.64

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference